Schedule a Meeting Today | Visit Catalent Experts at AAPS: Booth #1727

Join Catalent at AAPS to Debate Latest Applied Development Approaches

We have the passion to unlock the potential of your small and large molecules. With expanded early development solutions, and the acquisition of Juniper Pharmaceuticals. Catalent has you covered from candidate selection to commercialization. Visit us at booth 1727 to November 4-7 to debate, discover and learn more about new approaches, latest technologies and best practices in drug development

Four presentation  Six research posters In-booth networking reception Pharma consultant breakfast session Catalent experts available during AAPS community socials   Schedule a meeting with our experts during the event.

Check Out our Networking Opportunities

Don’t Miss our Networking Reception on November 5   Join us on Monday, November  5th, at booth 1727 from 3:30 – 5 p.m. to network with Catalent experts and industry colleagues, enjoy refreshments, and dive deeper into the topics being discussed with our experts. Pharma Consultant Breakfast Session on November 6   Hear from experienced industry colleagues on the latest tips that will help your clients avoid critical pitfalls, and leverage CDMO experts. Enjoy a complimentary breakfast minutes away from the exhibit hall. Limited availability.

Hear Leading Catalent & Industry Experts on the Latest Trends

Monday, November 5th Sessions 9:30 a.m., “Automated Solutions for Non-GMP/GMP Bioassays for Biological Drug Development, Now and Future State”.  Jeff Dixon, Principal Scientist, Catalent, will explain the benefits of assay automation and explore its future direction. 2 p.m., “Cutting Edge Analytical Techniques to Expedite Drug Development”.Ronak Savla, Pharm.D., Ph.D., Scientific Affairs Manager, will moderate the panel session on latest analytical approaches for accelerating development.   Tuesday, November 6th Sessions 10:30 a.m., “Does the DCS System Really Work in Determining the Most Effective Formulation Strategy?”, industry experts will debate the effectiveness of the DCS, questioning its usefulness in identifying bioavailability issues and will use case studies to illustrate the merits of DCS evaluation. hosted by Stephen Tindal, Director, Science & Technology, Catalent 3:30 p.m., “Patient-Focused Drug Design – a View from the R&D Front Lines”. Cornell Stamoran, Ph.D., Vice President of Strategy and Co-Chair of the Catalent Applied Drug Delivery Institute, will lead a discussion on creating better treatments for patients through better drug design.

Debate & Challenge our Experts

Challenge us and meet Catalent Scientists and other industry experts for a free consultation over refreshments during and after the NEW AAPS community Social Hours at the HUB and Catalent booth next to it! Experts will be on hand to continue the conversation and discuss how Catalent approaches each Community Social topic.   For full details on the event click here to view the full agenda.

Latest Research on Drug Development Challenges

Article: New Techniques for Analytical “Bioassay” Cell Banking Article: Ensuring Success in Early Biopharmaceutical Formulation Development eBook: Advances in Analytical Technology for Biopharmaceuticals eBook: Trends in Manufacturing of Specialty Products eBook: Why Formulation Technologies are Critical to the Success of the Next Generation of Small Molecule Oral Drugs Brochure: Customized Manufacturing Article: A Roadmap for Successful Technology Transfer